Mean developmental outcome, height, weight, BMI, MUAC and HC in preadolescence, by intervention group
| Outcome | Control (SP twice) (n=333) Mean (SD) | Monthly SP (n=333) Mean (SD) | AZI-SP (n=336) Mean (SD) | Global p value | Global p value, adjusted* |
| Raven’s score† | 14.2 (3.7) | 14.4 (3.8) | 14.2 (3.9) | 0.8 | 0.8 |
| Height (cm) | 142.7 (8.1) | 142.5 (8.2) | 143.1 (8.4) | 0.6 | 0.7 |
| Weight (kg) | 33.8 (6.3) | 33.8 (6.9) | 34.2 (6.5) | 0.6 | >0.9 |
| BMI | 16.4 (1.7) | 16.5 (2.1) | 16.5 (1.6) | 0.7 | 0.9 |
| MUAC (cm) | 19.9 (2.1) | 19.8 (2.3) | 20.0 (2.0) | 0.2 | 0.5 |
| HC (cm) | 51.6 (1.4) | 51.5 (1.6) | 51.8 (1.5) | 0.1 | 0.08 |
*Adjusted for child sex, age, socioeconomic status and pubertal stage at the time of developmental assessment and anthropometric measurements.
†For the Raven’s score n=331, n=332 and n=334.
AZI-SP, intervention group with monthly SP and two doses of azithromycin; BMI, body mass index; HC, head circumference; MUAC, mid-upper-arm circumference; SP, sulfadoxine-pyrimethamine.